Literature DB >> 30848362

High polymorphism rates in well-known T cell epitopes restricted by protective HLA alleles during HIV infection are associated with rapid disease progression in early-infected MSM in China.

Chuan He1,2,3,4, Xiaoxu Han1,2,3,4, Hui Zhang1,2,3,4, Fanming Jiang1,2,3,4, Minghui An1,2,3,4, Bin Zhao1,2,3,4, Haibo Ding1,2,3,4, Zining Zhang1,2,3,4, Tao Dong5,6, Hong Shang7,8,9,10.   

Abstract

T cell epitopes restricted by several protective HLA alleles, such as B*57, B*5801, B*27, B*51 and B*13, have been very well defined over the past two decades. We investigated 32 well-known T cell epitopes restricted by protective HLA molecules among 54 Chinese men who have sex with men (MSM) at the early stage of HIV-1 infection. Subjects in our cohort carrying protective HLA types did not exhibit slow CD4 T cell count decline (P = 0.489) or low viral load set points (P = 0.500). Variations occurred in 96.88% (31/32) of the known wild-type epitopes (rate 1.85-100%), and the variation rates of the strains of two CRF01_AE lineages were significantly higher than those of non-CRF01_AE strains (76.82% vs. 48.96%, P = 0.004; 71.27% vs. 8.96%, P = 0.025). Subjects infected with CRF01_AE exhibited relatively rapid disease progression (P = 0.035). Therefore, the lack of wild-type protective T cell epitopes restricted by classic protective HLA alleles in CRF01_AE HIV-1 strains may be one of the reasons why rapid disease progression is observed in Chinese MSM with HIV-1 infection.

Entities:  

Keywords:  Cytotoxic T lymphocytes; Disease progression; Epitope variants; Human immunodeficiency virus type 1; Human leukocyte antigen; Men who have sex with men

Mesh:

Substances:

Year:  2019        PMID: 30848362     DOI: 10.1007/s00430-019-00585-x

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  69 in total

Review 1.  Cellular immune responses to HIV.

Authors:  A J McMichael; S L Rowland-Jones
Journal:  Nature       Date:  2001-04-19       Impact factor: 49.962

2.  Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis. Collaborative Group on AIDS Incubation and HIV Survival including the CASCADE EU Concerted Action. Concerted Action on SeroConversion to AIDS and Death in Europe.

Authors: 
Journal:  Lancet       Date:  2000-04-01       Impact factor: 79.321

Review 3.  HIV T cell vaccines, the importance of clades.

Authors:  Andrew McMichael; Matilu Mwau; Tomás Hanke
Journal:  Vaccine       Date:  2002-05-06       Impact factor: 3.641

4.  AIDS restriction HLA allotypes target distinct intervals of HIV-1 pathogenesis.

Authors:  Xiaojiang Gao; Arman Bashirova; Astrid K N Iversen; John Phair; James J Goedert; Susan Buchbinder; Keith Hoots; David Vlahov; Marcus Altfeld; Stephen J O'Brien; Mary Carrington
Journal:  Nat Med       Date:  2005-11-20       Impact factor: 53.440

5.  Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA.

Authors:  Photini Kiepiela; Alasdair J Leslie; Isobella Honeyborne; Danni Ramduth; Christina Thobakgale; Senica Chetty; Prinisha Rathnavalu; Corey Moore; Katja J Pfafferott; Louise Hilton; Peter Zimbwa; Sarah Moore; Todd Allen; Christian Brander; Marylyn M Addo; Marcus Altfeld; Ian James; Simon Mallal; Michael Bunce; Linda D Barber; James Szinger; Cheryl Day; Paul Klenerman; James Mullins; Bette Korber; Hoosen M Coovadia; Bruce D Walker; Philip J R Goulder
Journal:  Nature       Date:  2004-12-09       Impact factor: 49.962

6.  Selective escape from CD8+ T-cell responses represents a major driving force of human immunodeficiency virus type 1 (HIV-1) sequence diversity and reveals constraints on HIV-1 evolution.

Authors:  Todd M Allen; Marcus Altfeld; Shaun C Geer; Elizabeth T Kalife; Corey Moore; Kristin M O'sullivan; Ivna Desouza; Margaret E Feeney; Robert L Eldridge; Erica L Maier; Daniel E Kaufmann; Matthew P Lahaie; Laura Reyor; Giancarlo Tanzi; Mary N Johnston; Christian Brander; Rika Draenert; Jurgen K Rockstroh; Heiko Jessen; Eric S Rosenberg; Simon A Mallal; Bruce D Walker
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

7.  Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection.

Authors:  Eberhard W Fiebig; David J Wright; Bhupat D Rawal; Patricia E Garrett; Richard T Schumacher; Lorraine Peddada; Charles Heldebrant; Richard Smith; Andrew Conrad; Steven H Kleinman; Michael P Busch
Journal:  AIDS       Date:  2003-09-05       Impact factor: 4.177

8.  Immune escape precedes breakthrough human immunodeficiency virus type 1 viremia and broadening of the cytotoxic T-lymphocyte response in an HLA-B27-positive long-term-nonprogressing child.

Authors:  M E Feeney; Y Tang; K A Roosevelt; A J Leslie; K McIntosh; N Karthas; B D Walker; P J R Goulder
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

9.  HIV evolution: CTL escape mutation and reversion after transmission.

Authors:  A J Leslie; K J Pfafferott; P Chetty; R Draenert; M M Addo; M Feeney; Y Tang; E C Holmes; T Allen; J G Prado; M Altfeld; C Brander; C Dixon; D Ramduth; P Jeena; S A Thomas; A St John; T A Roach; B Kupfer; G Luzzi; A Edwards; G Taylor; H Lyall; G Tudor-Williams; V Novelli; J Martinez-Picado; P Kiepiela; B D Walker; P J R Goulder
Journal:  Nat Med       Date:  2004-02-08       Impact factor: 53.440

10.  Fitness cost of escape mutations in p24 Gag in association with control of human immunodeficiency virus type 1.

Authors:  Javier Martinez-Picado; Julia G Prado; Elizabeth E Fry; Katja Pfafferott; Alasdair Leslie; Senica Chetty; Christina Thobakgale; Isobel Honeyborne; Hayley Crawford; Philippa Matthews; Tilly Pillay; Christine Rousseau; James I Mullins; Christian Brander; Bruce D Walker; David I Stuart; Photini Kiepiela; Philip Goulder
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

View more
  4 in total

1.  Analysis of temporal changes in HIV-1 CRF01_AE gag genetic variability and CD8 T-cell epitope evolution.

Authors:  Wardah Rafaqat; Uroosa Tariq; Nida Farooqui; Maheen Zaidi; Aanish Raees; Maaz Zuberi; Amna Batool; Syed Hani Abidi
Journal:  PLoS One       Date:  2022-05-10       Impact factor: 3.752

2.  HIV-1-Specific Immunodominant T-Cell Responses Drive the Dynamics of HIV-1 Recombination Following Superinfection.

Authors:  Hui Zhang; Shuang Cao; Yang Gao; Xiao Sun; Fanming Jiang; Bin Zhao; Haibo Ding; Tao Dong; Xiaoxu Han; Hong Shang
Journal:  Front Immunol       Date:  2022-01-14       Impact factor: 7.561

3.  A longitudinal analysis of immune escapes from HLA-B*13-restricted T-cell responses at early stage of CRF01_AE subtype HIV-1 infection and implications for vaccine design.

Authors:  Hui Zhang; Chuan He; Fanming Jiang; Shuang Cao; Bin Zhao; Haibo Ding; Tao Dong; Xiaoxu Han; Hong Shang
Journal:  BMC Immunol       Date:  2022-04-02       Impact factor: 3.615

4.  Using molecular network analysis to explore the characteristics of HIV-1 transmission in a China-Myanmar border area.

Authors:  Yuying Zhang; Jie Dai; Zhengxu Li; Yanling Ma; Huichao Chen; Lijuan Dong; Xiaomei Jin; Min Yang; Zhijun Zeng; Pengyan Sun; Anyan Hu; Min Chen
Journal:  PLoS One       Date:  2022-05-06       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.